PRP Injection — Joint Pain & Osteoarthritis

Platelet-Rich Plasma injections for knee, hip, and shoulder joint pain including osteoarthritis and cartilage injuries. Using the patient's own concentrated platelets, PRP stimulates natural tissue repair and reduces inflammation without surgery.

PRP (Platelet-Rich Plasma) joint injections at Ray of Health offer a minimally invasive regenerative option for patients suffering from joint pain caused by osteoarthritis, cartilage injuries, meniscus tears, and ligament damage. The treatment harnesses the body's own healing biology — a small blood sample is drawn from the arm, spun in a centrifuge to concentrate the platelets up to five times their normal level, and then precisely injected into the affected joint under clinical guidance. Platelet-Rich Plasma contains high concentrations of growth factors including PDGF, TGF-β, VEGF, and IGF-1. When delivered directly into a damaged joint, these growth factors activate resident stem cells, promote collagen synthesis, reduce inflammatory mediators, and stimulate chondrocyte (cartilage cell) proliferation. The result is a gradual but meaningful reduction in pain and improvement in joint function over the weeks and months following injection. At Ray of Health, PRP joint injections are performed by Dr James Tan Chung Hui, a fellowship-trained orthopaedic surgeon with over a decade of sports surgery experience. Common indications include knee osteoarthritis (Kellgren-Lawrence Grade I–III), hip joint degeneration, shoulder osteoarthritis, meniscus tears unsuitable for immediate surgery, and ACL or MCL ligament injuries where conservative management is preferred. The procedure begins with a consultation to assess imaging, clinical history, and suitability. Local anaesthesia is applied to the injection site before the PRP is administered. Post-procedure, patients are monitored briefly and given comprehensive aftercare instructions covering activity modification, icing protocol, and expected symptom timeline. A follow-up review is scheduled at four to eight weeks to assess response. Most patients require one to three injections spaced four to six weeks apart, with results typically becoming evident six to twelve weeks after the final injection. The clinic accepts MediSave and Integrated Shield Plan coverage for eligible orthopaedic diagnoses, which may reduce out-of-pocket costs for qualifying patients. Corporate insurance arrangements are also available. This treatment is well-suited for patients who wish to delay or avoid joint replacement surgery, athletes seeking to return to sport, and older adults looking to maintain mobility and quality of life through regenerative medicine rather than long-term medication.